Thermogelling hydrogels of poly(ε-caprolactone-CO-D,L-lactide)-poly(ethylene glycol)-poly(ε-caprolactone-CO-D,L-lactide) and poly(ε-caprolactone-CO-L-lactide)poly(ethylene glycol)-poly(ε-caprolactone-CO-L-lactide) aqueous solutions

被引:47
作者
Jiang, Zhiqiang
Deng, Xianmo
Hao, Jianyuan
机构
[1] Chinese Acad Sci, Chengdu Inst Organ Chem, Chengdu 610041, Peoples R China
[2] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China
关键词
biomaterials; block copolymers; drug delivery systems; hydrogels; micelles; phase behavior; structure-property relations; transesterification;
D O I
10.1002/pola.22222
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Thermogelling poly(,epsilon-caprolactone-co-D,L-lactide)-poly(ethylene glycol)poly(epsilon-caprolactone-co-D,L-lactide) and poly(E-caprolactone-CO-L-lactide)-poly(ethylene glycol)-poly(P.-caprolactone-CO-L-lactide) triblock copolymers were synthesized through the ring-opening polymerization of e-caprolactone and D,L-lactide or L-lactide in the presence of poly(ethylene glycol). The polymerization reaction was carried out in 1,3,5-trimethylbenzene with Sn(Oct)(2) as the catalyst at various temperatures, and the yields were about 96%. The molecular weights and polydispersities (M-w/M-n) by gel permeation chromatography were in the ranges of 5140-6750 and 1.35-1.45, respectively. The differential scanning calorimetry results showed that the melting temperatures of the poly(g-caprolactone) components were between 30 and 40 degrees C. By the subtle tuning of the chemical compositions and microstructures of these triblock copolymers, the aqueous solutions underwent sol-gel transitions as the temperature increased, with the suitable lower critical solution temperature in the range of 1728 degrees C at different concentrations. Transesterification in the polymerization process generated the redistribution of sequences, which remarkably affected the sol-gel transition temperature. The amphiphilic copolymers formed micelles in aqueous solutions with a diameter of 62 nm and a critical micelle concentration of about 0.032 wt % at 20 degrees C. Micelles aggregated as the temperature increased, leading to gel formation. The sol-gel transition was studied, with a focus on the structure-property relationship. It is expected to have potential applications in drug delivery and tissue engineering.
引用
收藏
页码:4091 / 4099
页数:9
相关论文
共 41 条
[11]   Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres [J].
Fu, K ;
Pack, DW ;
Klibanov, AM ;
Langer, R .
PHARMACEUTICAL RESEARCH, 2000, 17 (01) :100-106
[12]   ANIONIC-POLYMERIZATION OF LACTONES INITIATED BY ALKALI GRAPHITIDES .5. INITIATION MECHANISM AND NATURE OF THE ACTIVE-CENTERS [J].
GITSOV, I ;
RASHKOV, IB ;
PANAYOTOV, IM .
JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY, 1990, 28 (08) :2115-2126
[13]   Degradation and cell culture studies on block copolymers prepared by ring opening polymerization of ε-caprolactone in the presence of poly(ethylene glycol) [J].
Huang, MH ;
Li, SM ;
Hutmacher, DW ;
Schantz, JT ;
Vacanti, CA ;
Braud, C ;
Vert, M .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2004, 69A (03) :417-427
[14]   Caprolactonic poloxamer analog: PEG-PCL-PEG [J].
Hwang, MJ ;
Suh, JM ;
Bae, YH ;
Kim, SW ;
Jeong, B .
BIOMACROMOLECULES, 2005, 6 (02) :885-890
[15]   Thermoreversible gelation of PEG-PLGA-PEG triblock copolymer aqueous solutions [J].
Jeong, B ;
Bae, YH ;
Kim, SW .
MACROMOLECULES, 1999, 32 (21) :7064-7069
[16]  
Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO
[17]  
2-F
[18]   Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers [J].
Jeong, B ;
Bae, YH ;
Kim, SW .
JOURNAL OF CONTROLLED RELEASE, 2000, 63 (1-2) :155-163
[19]   Biodegradable block copolymers as injectable drug-delivery systems [J].
Jeong, B ;
Bae, YH ;
Lee, DS ;
Kim, SW .
NATURE, 1997, 388 (6645) :860-862
[20]   Biodegradable triblock copolymer of PLGA-PEG-PLGA enhances gene transfection efficiency [J].
Jeong, JH ;
Kim, SW ;
Park, TG .
PHARMACEUTICAL RESEARCH, 2004, 21 (01) :50-54